Charlie Hurmiz, Chief Information Officer & Chief Data Science Officer, discusses GRN’s best practices for health data protection and security, including PHI Compliance, SOC 2, and our Honest Broker programs.

GRN is proud to have successfully completed the SOC 2 Type 2 Attestation for Security. Please refer to this document for questions and answers about this popular form of cybersecurity audit.

Adam Chasse, MHA, Executive VP & GM, Clinical Services, discusses how life sciences companies can accelerate the timeframe to finding patients for clinical trials by using EMR data from GRN.

Shirley Trainor-Thomas, MHSA, VP of Partner Network, comments on translating Electronic Medical Record (EMR) data into valuable, searchable information that can benefit a health system and its patients.

Explore this infographic on how GRN helps Life Sciences with precision medicine trials, real world data use, and data science support in diagnostic and therapeutic trials.

Read about how deep real world data with sophisticated analytics can help you bring safe and effective new therapies or diagnostics to market quicker.

Explore this infographic on how GRN helps Health Systems participate in precision medicine trials and improve patient access to novel therapies.

At Congressional subcommittee, Leroy Hood, MD, PhD. discussed GRN’s involvement in the “Beyond the Human Genome” project in 40 second video clip.

Watch this brief video interview with GRN’s Adam Chasse on how leveraging EMR data can improve trial efficacy and shorten timelines.